GCM
COLL icon

Graham Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Graham Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$330K Buy
9,986
+2,996
+43% +$127K 0.01% 782
2025
Q4 		$324K Buy
+6,990
New +$292K 0.01% 827
2024
Q3 		– Sell
-17,341
Closed -$558K – 1133
2024
Q2 		$558K Buy
17,341
+5,095
+42% +$177K 0.01% 545
2024
Q1 		$475K Buy
12,246
+4,683
+62% +$164K 0.01% 640
2023
Q4 		$233K Sell
7,563
-8,044
-52% -$202K 0.01% 797
2023
Q3 		$349K Buy
15,607
+5,503
+54% +$126K 0.01% 672
2023
Q2 		$217K Sell
10,104
-5,256
-34% -$119K 0.01% 791
2023
Q1 		$368K Buy
+15,360
New +$407K 0.01% 824

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return